logo

weixin 加入日历

Document


CPhI China Pharma Week – Plant Visit




Route 1: Natural Extract
Date: 2017.6.22 afternoon
Place: Jiaxing City, Zhejiang Province
Who should join: 15-20 Buyers/representatives from health products, food, pharma, cosmetics and trading companies



Plant to visit: Jiaixng Hengjie Biopharmaceutical Co., Ltd

Agenda:


6.22

13:00

Gathering at Overseas Visitor Lounge

13:30

Departure from SNIEC by Bus

15:00

Arrive in Jiaxing factory & Welcome

15:30

Factory Tour & Introduction

17:00

Dinner

18:00

Departure, back to Shanghai


Company Introduction:
As one of the earliest Chondroitin Sulfate manufacturers in China, Jiaixng Hengjie Biopharmaceutical Co., Ltd was founded in 1997 and has specialized in production and supply of Chondroitin Sulfate ever since. Chondroitin sulfate, Glucosamine, Shark cartilage powder and Type II Collagen are up to USP,EP,JP,CP and even customized with various cartilage origins available. The capacity of production is estimated to be more 20MT per month. Certificates obtained include NSF-GMP, HALAL, DMF and etc. With outstanding quality, the company has gained a good reputation world-wide.


Chondroitin sulfate is obtained from terrestrial such as bovine, porcine or avian cartilages of healthy and domestic animals used for food by humans. It is also obtained from cartilage marine origin such as shark.


Glucosamine is extracted from crab and shell which can be made into Glucosamine HCL and Glucosamine sulfate.


Shark cartilage powder is crushed from shark bone directly, which uses cryogenic crush tech and ensures the activity of protein.


II type Collagen helps maintain the integrity and biomechanical properties of bone structure. It also could help prevent the loss of calcium and thus is widely used in bone health-care products.


The plant is more than 20 thousand square meters with over 100 staff. Equipped with modern apparatus and leading inspection instruments, a GMP-approved plant was built in 2008. The Laboratory was named by Jiaxing municipal people's government High-Tech Research and Development Center.


The company pays great attention to technological innovation, for a number of utility model patents. In order to ensure the sustainable development of product innovation and technology enterprises, the company employed some Dr. who lead the team to forward.


The company insists on quality and innovative technology and to provide the most professional service for customers.




Route 2: Innovation companies 
Date: 2017.6.22 afternoon
Place:Zhangjiang High-Tech Park, Shanghai
Who should join: Representatives of R&D, Finished Dosage, API companies


Companies to visit:
Sundia MediTech Company Ltd. & Shanghai Bocimed Pharmaceutical Co., Ltd.


Agenda:


6.22

13:00

Gathering at Overseas Visitor Lounge

13:30

Departure from SNIEC

13:50

Arrive at Zhangjiang High-Tech Park & Welcome

14:00

R&D Center Visit & Introduction

15:00

Set off for second company

15:20

Arrival at second company and welcome

16:00

R&D Center Visit & Introduction

17:00

Get back to the venue


Company Introduction:

  • Sundia MediTech Company Ltd.

Founded in 2004, Sundia MediTech Company Ltd. is a leading China-based CRO providing a broad range of high-quality, cost effective drug discovery and development services. Capitalizing on its broad service offerings, experienced scientists and advanced research facilities and equipment, Sundia helps its customers discover and develop novel drug candidates efficiently. Sundia currently provides services to over 160 customers globally, including a vast majority of the top 20 pharmaceutical and biotechnology companies in the world, as well as fast-growing biotechnology and specialty pharmaceutical companies and renowned academic and research institutions. Sundia currently boasts an experienced and strong R&D tem, comprised of over 700 employees, of over 70% have post-graduate degrees and an average of 15 years of relevant industry experience.


With the comprehensive service offering, scale up, process development, formulation development and analytical development, Sundia are able to tailor project resources to meet the client's specific needs and deliver CMC document that compliance to global GMP standard.

Sundia provides a broad scope of development solutions, ranging from Route Discovery and Design, Process Improvement and Optimization, Process Robustness Testing, Salt and Polymorph Screening and Selection, Process Scale-up, Technology Transfer from research to Commercial Scale, Multi-grams to Multi-tons Manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates in compliance to cGMP guidelines.

Facilities:

  • Lab space: 35,000 SF
  • 120 research fume hood in Process lab
  • Non-GMP kilo lab: 17 reactors from 50-100L
  • cGMP Kilo lab: 5 reactors from 100-200L
  • Low temp reaction capability: -80C
  • Pressure reaction up to 1MPa (120psi)
  • Clean room for API production
  • Non-GMP Pilot plant with 20 reactors from 300L-5000L (in Taicang)

Shanghai Bocimed Pharmaceutical Co., Ltd.


Shanghai Bocimed Pharmaceutical Co., Ltd., located in Shanghai Zhangjiang High-Tech Park, is a high-tech enterprise certificated by Shanghai government. In the R&D team with more than 100 members, 40% have Ph.D. or Master Degree. The R&D center of the company is more than 2500m2, and the investment for the facilities is above 20 million RMB. Bocimed is among the earliest which has got the ISO9001:2015 certification.


The company is engaged in the whole process of drug development including R&D of high-end generic drugs, quality consistency evaluation for generic drugs, clinical research and registration service, and provides pharmaceutical companies as well as the company itself with highly-competitive new drugs.


In the 10 years after the company was founded, Bocimed has established cooperation with about 100 local and foreign pharmaceutical companies and has got good reputation. Bocimed is also listed in Top 50 Strengths of pharmaceutical R&D enterprises in China.


 


*Fee for visit:
Register before the show: Free of charge
Register onsite: Euro79/person, RMB 600

全产业链解决方案: 结识新客户,碰撞新思想,把握新商机。